TAIWAN · TWSE / TPEx
Cenra Inc.
中化控股 · 3716 · TWSE (main board) · Biotech and medical
Share price, 2026-10-19NT$33.851 month +0.4% · 1 year +4.1%
Directors and supervisors hold15,443,95610.3% of shares issued
Of which pledged39.8%6,150,000
Major shareholders (10%+) hold21,026,56814.0% of shares issued
Revenue, 2026-09-11.0%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 財團法人王民寧先生紀念基金會 | Chairman | 5,216,456 | 5,216,456 | 3.46% | — | — |
| 王謝怡貞 | Chairman (corporate representative) | — | 47,288 | 0.03% | — | 8,932,893 |
| 王厚傑 | Director | 3,467,000 | 3,660,000 | 2.43% | — | — |
| 磐石控股股份有限公司 | Director | 6,540,500 | 6,567,500 | 4.36% | 6,150,000 | — |
| 王厚凱 | Director (corporate representative) · President | — | 129,204 | 0.09% | — | — |
| 陳宏守 | Independent director | — | 0 | — | — | — |
| 周大任 | Independent director | — | 0 | — | — | — |
| 呂嘉蕙 | Independent director | — | 0 | — | — | — |
| 王德頻 | Independent director | — | 0 | — | — | — |
| 吳世璿 | Vice president · Chief financial officer | — | 16,051 | 0.01% | — | — |
| 唐莉蓁 | Vice president | — | 5,600 | 0.00% | — | — |
| 陳誼芬 | Manager | — | 0 | — | — | — |
| 林珍岑 | Manager | — | 9,333 | 0.01% | — | — |
| 黃宜均 | Manager | — | 53,000 | 0.04% | — | — |
| 中化合成生技股份有限公司 | Major shareholder (10%+) | — | 21,026,568 | 13.96% | — | — |
| 江顯杰 | Chief accountant | — | 0 | — | — | — |